- Conditions
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell Carcinoma, Metastatic Laryngeal Squamous Cell Carcinoma, Metastatic Nasopharyngeal Squamous Cell Carcinoma, Metastatic Oral Cavity Squamous Cell Carcinoma, Metastatic Oropharyngeal Squamous Cell Carcinoma, Metastatic Sinonasal Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Nasopharyngeal Squamous Cell Carcinoma, Recurrent Oral Cavity Squamous Cell Carcinoma, Recurrent Oropharyngeal Squamous Cell Carcinoma, Recurrent Sinonasal Squamous Cell Carcinoma, Squamous Cell Carcinoma of Unknown Primary, Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8, Stage IV Hypopharyngeal Carcinoma AJCC v8, Stage IV Laryngeal Cancer AJCC v8, Stage IV Lip and Oral Cavity Cancer AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8, Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IV Sinonasal Cancer AJCC v8
- Interventions
- Autologous Tumor Membrane Vesicles Vaccine, Biospecimen Collection, Computed Tomography, Echocardiography, Magnetic Resonance Imaging, Pembrolizumab, Positron Emission Tomography, Surgical Procedure
- Biological · Procedure
- Lead sponsor
- Emory University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2028
- U.S. locations
- 2
- States / cities
- Atlanta, Georgia
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 2713–2736
of 6,439
matching trials from the local directory fallback.
- Conditions
- Cancer
- Interventions
- Existing patient instructions, Modernized patient instructions
- Behavioral
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 650 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- Autoimmune Diseases, Cancer
- Interventions
- Fertility-Based Labwork, Infectious Disease Labwork
- Diagnostic Test
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- Up to 39 Years · Female only
- Enrollment
- 500 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2031
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Placebo, Semaglutide Pen Injector
- Drug
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 18 Years to 49 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 2
- States / cities
- Aurora, Colorado • Seattle, Washington
- Conditions
- Anxiety Disorders, Borderline Personality Disorder, Eating Disorders, Emotion Dysregulation, Emotion Regulation, Emotional Distress, Emotional Dysfunction, Emotional Impulsivity, Emotional Instability, Emotional Maladjustment, Impulse Control Disorder, Mood Disorders, OCD, Obsessive-Compulsive Disorder, Stress Disorder
- Interventions
- Cognitive Restructuring, Emotional Awareness Training, Repetitive Transcranial Magnetic Stimulation (rTMS), electrical scalp stimulation
- Behavioral · Device
- Lead sponsor
- Duke University
- Other
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 240 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Deafness
- Interventions
- Electric-only spectral resolution, Modulation Detection Threshold (MDT) and Gap Detection Tasks, Single-Electrode Pulse Train, Sound coding strategy.
- Other
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 6 Years to 80 Years
- Enrollment
- 190 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2027
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Advanced Cancer, Advanced Solid Tumor, Behavior Disorders, Cancer, Mental Health Issue
- Interventions
- Drug-Drug Interaction Profile, Drug-Gene Interaction Profile, Standard of Care
- Other
- Lead sponsor
- University of Chicago
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Malignant Brain Glioma
- Interventions
- Magnetic Resonance Spectroscopic Imaging, Proton Therapy
- Procedure · Device
- Lead sponsor
- Emory University
- Other
- Eligibility
- Up to 21 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2030
- U.S. locations
- 3
- States / cities
- Atlanta, Georgia
- Conditions
- Anal Cancer, Cervical Cancer, HPV-Related Anal Squamous Cell Carcinoma, HPV-Related Carcinoma, HPV-Related Cervical Carcinoma, Uterine Cervical Cancer
- Interventions
- Blood Sample Collection, HPV Genotyping (HPV DNA Test), Physical Exam, Positron Emission Tomography Scan (PET Scan)/ Computed Tomography Scan (CT Scan), Radiation Treatment With or Without Chemotherapy, Testing Archival Tumor Tissue
- Other · Diagnostic Test · Radiation
- Lead sponsor
- University of Chicago
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2027
- U.S. locations
- 2
- States / cities
- Chicago, Illinois
- Conditions
- Chronic Pain, Opioid-use Disorder
- Interventions
- Active Comparator: Active tDCS + Active TUS, Sham Comparator: Sham tDCS + Sham TUS
- Device
- Lead sponsor
- Case Western Reserve University
- Other
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 126 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2027
- U.S. locations
- 3
- States / cities
- Hinsdale, Illinois • Cambridge, Massachusetts • Cleveland, Ohio
- Conditions
- Birth Defect, Brugada Syndrome, Congenital Heart Disease, Fetal Arrhythmia, Fetal Cardiac Anomaly, Fetal Cardiac Disorder, Fetal Death, Fetal Demise, Fetal Hydrops, Fetal Tachycardia, Gastroschisis, High Risk Pregnancy, Intrauterine Fetal Death, Long QT Syndrome, Pregnancy Loss, Stillbirth, Sudden Infant Death, Twin Monochorionic Monoamniotic Placenta, Twin Twin Transfusion Syndrome
- Interventions
- Fetal Magnetocardiogram and Neonatal Electrocardiogram, Substudy only: Maternal/Infant Pharmacogenomic assessment postnatally
- Diagnostic Test · Genetic
- Lead sponsor
- Medical College of Wisconsin
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2028
- U.S. locations
- 2
- States / cities
- Madison, Wisconsin • Milwaukee, Wisconsin
- Conditions
- Children, Congenital Heart Diseases
- Interventions
- structured physical activity program
- Other
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 30 Months to 6 Years
- Enrollment
- 300 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2028
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Malignant Glioma
- Interventions
- Biospecimen Collection, Magnetic Resonance Imaging, T2 (Observed)-Weighted Imaging
- Procedure
- Lead sponsor
- John M. Buatti
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2028
- U.S. locations
- 1
- States / cities
- Iowa City, Iowa
- Conditions
- Cystic Fibrosis (CF), Depressive and Anxiety Disorders, Psychological Flexibility
- Interventions
- ACT with CF Self-Help Toolkit, Waitlist
- Behavioral · Other
- Lead sponsor
- Thomas Jefferson University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Recurrent Transformed B-Cell Non-Hodgkin Lymphoma, Recurrent Transformed Chronic Lymphocytic Leukemia, Recurrent Transformed Non-Hodgkin Lymphoma, Refractory Transformed, Refractory Transformed B-cell Non-Hodgkin Lymphoma, Refractory Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Non-Hodgkin Lymphoma, Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma
- Interventions
- Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Cyclophosphamide, Fludarabine, Leukapheresis, Lisocabtagene Maraleucel, Lymph Node Biopsy, Positron Emission Tomography, Zanubrutinib
- Procedure · Drug · Biological
- Lead sponsor
- Aseel Alsouqi
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 3
- States / cities
- New York, New York • Columbus, Ohio • Salt Lake City, Utah
- Conditions
- Primary Central Nervous System Lymphoma, Refractory Cancer, Relapsed Cancer, Secondary Central Nervous System Lymphoma
- Interventions
- Autologous Stem Cell Transplant (ASCT), Pemetrexed, Whole Brain Radiation Therapy (WBRT), Zanubrutinib
- Procedure · Drug · Radiation
- Lead sponsor
- Baptist Health South Florida
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2033
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- HIV Prevention, HIV Treatment
- Interventions
- At Home Self-Collections
- Other
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2027
- U.S. locations
- 1
- States / cities
- Aurora, Colorado
- Conditions
- Bipolar Depression, Bipolar Disorder, Major Depression, Major Depressive Disorder, Major Depressive Episode, Obsessive-Compulsive Disorder, Treatment Resistant Depression
- Interventions
- Deep Transcranial Magnetic Stimulation (dTMS), Electroconvulsive Therapy (ECT), Esketamine, Ketamine, Transcranial Magnetic Stimulation (TMS)
- Device · Drug
- Lead sponsor
- Mark Niciu
- Other
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 1,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2050
- U.S. locations
- 1
- States / cities
- Iowa City, Iowa
- Conditions
- Digestive System Neuroendocrine Tumor, Unresectable Digestive System Neuroendocrine Neoplasm, Unresectable Digestive System Neuroendocrine Tumor G1, Unresectable Digestive System Neuroendocrine Tumor G2
- Interventions
- Computed Tomography, Gallium Ga 68-DOTATATE, Lutetium Lu 177 Dotatate, Magnetic Resonance Imaging, Positron Emission Tomography, Questionnaire Administration, Stereotactic Body Radiation Therapy
- Procedure · Radiation · Drug + 1 more
- Lead sponsor
- Emory University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 2
- States / cities
- Atlanta, Georgia
- Conditions
- COVID-19
- Interventions
- Subjects with and without Long COVID
- Biological
- Lead sponsor
- University of Chicago
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 400 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Community Acquired Pneumonia in Children
- Interventions
- Amoxicillin, Amoxicillin-clavulanate, Ampicillin / Sulbactam Injection, Ampicillin for Injection, Cefprozil, Ceftriaxone for Injection, Clindamycin, Levofloxacin
- Drug
- Lead sponsor
- Medical College of Wisconsin
- Other
- Eligibility
- 3 Months to 18 Years
- Enrollment
- 236 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 1
- States / cities
- Milwaukee, Wisconsin
- Conditions
- HER2-positive Breast Cancer
- Interventions
- HER-2 pulsed DC1, Paclitaxel, Pertuzumab, Resection surgery, Trastuzumab
- Biological · Drug · Procedure
- Lead sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 53 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2027
- U.S. locations
- 1
- States / cities
- Tampa, Florida
- Conditions
- Prostate Cancer, Recurrent Prostate Cancer
- Interventions
- F-DCFPyL Injection, PSMA PET
- Drug · Diagnostic Test
- Lead sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2029
- U.S. locations
- 1
- States / cities
- Tampa, Florida
- Conditions
- Mental Disorder, Psychotic Disorder, Schizophrenia Disorders
- Interventions
- Intracranial electrodes, TMS, TMS sham
- Device
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Stanford, California